+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Anti-Cancer MAbS Market Report 2026 - Product Thumbnail Image

Anti-Cancer MAbS Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Oncology Pharmaceuticals Market - Product Thumbnail Image

Oncology Pharmaceuticals Market

  • Report
  • October 2024
  • 181 Pages
  • Global
From
Pulmonary Embolism Therapeutics Market 2025-2029 - Product Thumbnail Image

Pulmonary Embolism Therapeutics Market 2025-2029

  • Report
  • June 2025
  • 206 Pages
  • Global
From
Gene Editing Therapeutics Market - Product Thumbnail Image

Gene Editing Therapeutics Market

  • Report
  • August 2024
  • 111 Pages
  • Global
From
HP (High Potency) APIs Market Report 2026 - Product Thumbnail Image

HP (High Potency) APIs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Leukemia Therapeutics Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Leukemia Therapeutics Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Small Molecule Active Pharmaceutical Ingredient Market Report 2026 - Product Thumbnail Image

Small Molecule Active Pharmaceutical Ingredient Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Liposomal Drug Delivery Devices Market Report 2026 - Product Thumbnail Image

Liposomal Drug Delivery Devices Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Facial Palsy - Global Strategic Business Report - Product Thumbnail Image

Facial Palsy - Global Strategic Business Report

  • Report
  • April 2026
  • 367 Pages
  • Global
From
Catecholamines - Global Strategic Business Report - Product Thumbnail Image

Catecholamines - Global Strategic Business Report

  • Report
  • April 2026
  • 372 Pages
  • Global
From
Neuralgia Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuralgia Treatment - Global Strategic Business Report

  • Report
  • April 2026
  • 276 Pages
  • Global
From
From
Cytomegalovirus (CMV) Therapeutics Market 2026-2030 - Product Thumbnail Image

Cytomegalovirus (CMV) Therapeutics Market 2026-2030

  • Report
  • January 2026
  • 289 Pages
  • Global
From
From
From
Loading Indicator